Biomonitoring of smoke constituents: Exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers

Inhalation Toxicology

Volumn 22, Issue 9, 2010, Pages 725-737

  Schorp, Matthias K ^a   Leyden, Donald E ^b  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b NONE

Author keywords

4 aminobiphenyl; 4 aminobiphenyl hemoglobin adducts; environmental tobacco smoke (ETS); smoking; Toxicokinetics

Indexed keywords

4 AMINOBIPHENYL HEMOGLOBIN; 4 BIPHENYLAMINE; BIPHENYL DERIVATIVE; CARCINOGEN; TOBACCO SMOKE; UNCLASSIFIED DRUG; 4-BIPHENYLAMINE; AMINOBIPHENYL DERIVATIVE; HEMOGLOBIN; PASSIVE SMOKING;

ADULT; ARTICLE; BIOLOGICAL MONITORING; ENVIRONMENTAL EXPOSURE; HOME; HOSPITAL; HUMAN; MALE; MONTE CARLO METHOD; PRIORITY JOURNAL; SMOKING; STEADY STATE; WORKPLACE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; ENVIRONMENTAL MONITORING; FEMALE; METABOLISM; PASSIVE SMOKING; PROCEDURES;

NICOTIANA TABACUM;

ADULT; AMINOBIPHENYL COMPOUNDS; ANIMALS; CARCINOGENS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; HEMOGLOBINS; HUMANS; MALE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; TOBACCO SMOKE POLLUTION;

EID: 77954794154     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958371003717043     Document Type: Article

References (95)

1. Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, Manzi L, Veglia F, Autrup H, Dunning A, Garte S, Hainaut P, Hoek G, Krzyzanowski M, Malaveille C, Matullo G, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Peluso M, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Chirlaque MD, Quiros JR, Berglund G, Jarvholm B, Hallmans G, Day NE, Allen N, Saracci R, Kaaks R, Riboli E. (2005). 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiol Biomarkers Prev, 14, 2118-2124. (Pubitemid 41603255)
2. American Industrial Health Council. (1994). Exposure Factors Sourcebook. Washington DC: American Industrial Health Council.
3. Armitage AK, Dixon M, Frost BE, Mariner DC, Sinclair NM. (2004). The effect of tobacco blend additives on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations during cigarette smoking. Chem Res Toxicol, 17, 537-544.
4. Bartsch H, Caporaso N, Coda M, Kadlubar F, Malaveille C, Skipper PL, Talaska G, Tannenbaum SR, Vineis P. (1990). Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst, 82, 1826-1831.
5. Benowitz NL. (2008). Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther, 83, 531-541.
6. Bergmark E, Belew M, Osterman-Golkar S. (1990). Separation and enrichment of alkylated goblin chains as a means of improving the sensitivity of hemoglobin adduct measurements. Acta Chem Scand, 44, 630-635.
7. Bernert JT, Jain RB, Pirkle JL, Wang L, Miller BB, Sampson EJ. (2005). Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes. Nicotine Tob Res, 7, 729-738.
8. BestFit. (2000). Version 4. Newfield, NY: Palisade Corporation.
9. Beyerbach A, Rothman N, Bhatnagar BK, Kashyap R, Sabbioni G. (2006). Hemoglobin adducts in workers exposed to benzidine an azo dyes. Carcinogenesis, 27, 1600-1606.
10. Bohanon HR Jr, Piade J-J, Schorp M, Saint-Jalm Y. (2003). An international survey of indoor air quality, ventilation and smoking activity in restaurants: a pilot study. J Expo Anal Environ Epidemiol, 13, 378-392.
11. Bois FY, Krowech G, Zeise L. (1995). Modeling the human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl. Risk Anal, 15, 205-213.
12. Branner B, Kutzer C, Zwickenpflug W, Scherer G, Heller W-D, Richter E. (1998). Haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and non-smoking women. Biomarkers, 3, 35-47.
13. Bryant MS. (1987). Estimation of human exposure to the carcinogenic aromatic amine 4-aminobiphenyl via hemoglobin dosimetry. PhD Thesis. Department of Biological Sciences. Cambridge, MA, Massachusetts Institute of Technology.
14. Bryant MS, Skipper PL, Tannenbaum SR, Maclure M. (1987). Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res, 47, 602-608.
15. Bryant MS, Vineis P, Skipper PL, Tannenbaum SR. (1988). Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci USA, 85, 9788-9791.
16. Byrd GD, Davis RA, Robinson JH, Caldwell WS, deBethizy JD. (1998). A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology, 139, 291-299.
17. California EPA. (1997). Health Effects of Exposure to Environmental Tobacco Smoke. Sacramento, CA: California Environmental Protection Agency's Office of Environmental Health Hazard Assessment. Final Report.
18. Cohen SM, Boobis AR, Meek ME, Preston RJ, McGregor DB. (2006). 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS human relevance framework for analysis of a cancer mode of action for humans. Crit Rev Toxicol, 36, 803-819.
19. Counts ME, Morton MJ, Laffoon SW, Cox RH, Lipowicz PJ. (2005). Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul Toxicol Pharmacol, 41, 185-227.
20. Crawford FG, Mayer J, Santella RM, Cooper TB, Ottman R, Tsai W-Y, Simon-Cereijido G, Wang M, Tang D, Perera FP. (1994). Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst, 86, 1398-1402.
21. Dallinga JW, Haenen GRMM, Bast A, Van Schooten F-J. (2002). The effect of the trolox equivalent antioxidant capacity (TEAC) in plasma on the formation of 4-aminobiphenylhaemoglobin adducts in smokers. Biomarkers, 7, 291-298.
22. DeBord DG, Swearengin TF, Cheever KL, Booth-Jones AD, Wissinger LA. (1992). Binding characteristics of ortho-toluidine to rat hemoglobin and albumin. Arch Toxicol, 9, 271-276.
23. Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I. (1974). Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res, 24, 93-103.
24. European Committee for Standardization. (2004). European Standard EN 13779 Ventilation for Non-residential Buildings-Performance Requirements for Ventilation and Room-conditioning Systems. Brussels, BE, European Committee for Standardization.
25. Falter B, Kutzer C, Richter E. (1994). Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin Investig, 72, 364-371.
26. Fennel TR, Sumner SC, Walker VE. (1992). A model for the formation and removal of hemoglobin adducts. Cancer Epidemiol Biomarkers Prev, 1, 213-219.
27. Fowles J, Dybing E. (2003). Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control, 12, 424-430.
28. Frost-Pineda K, Zedler BK, Oliveri D, Feng S, Liang Q, Roethig H-J. (2008a). Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol, 52, 104-110.
29. Frost-Pineda K, Zedler BK, Oliveri D, Liang Q, Feng S, Roethig H-J. (2008b). 12 Week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol, 52, 111-117.
30. Gan J, Skipper PL, Gago-Dominques M, Arakawa K, Ross RK, Yu MC, Tannenbaum SR. (2004). Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst, 96, 1425-1431.
31. Granath F, Ehrenberg L, Tornqvist M. (1992). Degree of alkylation of macromolecules in vivo from variable exposure. Mutat Res, 284, 297-306.
32. Green LC, Skipper PL, Turesky RJ, Bryant MS, Tannenbaum SR. (1984). In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Res, 44, 4254-4259.
33. Hammond SK, Coghlin J, Gann PH, Paul M, Taghizadeh K, Skipper PL, Tannenbaum SR. (1993). Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Natl Cancer Inst, 85, 474-478. (Pubitemid 23084092)
34. Hiller FC, McCusker KT, Mazumder MK, Wilson JD, Bone RC. (1982). Deposition of sidestream cigarette smoke in the human respiratory tract. Am Rev Respir Dis, 125, 406-408.
35. Hoffmann D, Hoffmann I. (1998). Cigars: health effects and trends. In: Shopland DR, Burns DM, Hoffman D, Cummings KM, Amacher H, eds. Chemistry and Toxicology, NCI Monograph 9. Washington DC: National Cancer Institute.
36. Hofmann W, Morawska L, Bergmann R. (2001). Environmental tobacco smoke deposition in the human respiratory tract: differences between experimental and theoretical approaches. J Aerosol Med, 14, 317-326.
37. Husgafvel-Pursiainen K. (2002). Biomarkers in the assessment of exposure and the biological effects of environmental tobacco smoke. Scand J Work Environ Health, 28, 21-29.
38. IARC. (1987). Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, Supplement 7. Lyon, France: International Agency for Research on Cancer.
39. IARC. (2004). Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer, 83, 1-1438.
40. ICRP. (2003). International Commission on Radiological Protection Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values. Oxford: Pergamon Press.
41. ISO. (2000). ISO 3308:2000 Routine Analytical Cigarette-smoking Machine- Definitions and Standard Conditions. Geneva: International Organization for Standardization.
42. Jarvis MJ, Boreham R, Primatesta P, Feyerabend C, Bryan A. (2001). Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J Natl Cancer Inst, 93, 134-138.
43. Jenkins RA, Guerin MR, Tomkins BA. (2000). The Chemistry of Environmental Tobacco Smoke: Composition and Measurement. Boca Raton, LA: Lewis Publishers.
44. Jenkins RA, Palausky A, Counts RW, Bayne CK, Dindal AB, Guerin MR. (1996). Exposure to environmental tobacco smoke in sixteen cities in the United States as determined by personal breathing zone air sampling. J Expo Anal Environ Epidemiol, 6, 473-502.
45. Jiang X, Yuan J-M, Skipper P, Tannenbaum S, Yu M. (2007). Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res, 67, 7540-7545. (Pubitemid 47206585)
46. Ketelslegers HB, Godschalk RW, Eskens BJ, Dallinga JW, Gottschalk RW, van Schooten FJ, van Delft JH, Kleinjans JC. (2009). Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans. Mol Carcinog, 48, 685-691.
47. LaKind JS, Ginevan ME, Naiman DQ, James AC, Jenkins RA, Dourson ML, Felter SP, Graves CG, Tardiff RG. (1999). Distribution of exposure concentrations and doses for constituents of environmental tobacco smoke. Risk Anal, 19, 375-390.
48. Luceri F, Pieraccini G, Moneti G, Dolara P. (1993). Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol Ind Health, 9, 405-413.
49. LUDEP 2.0. (1996). LUDEP 2.0, Personal Computer Program for Calculating Internal Doses Using the ICRP Publication 66 Respiratory Tract Model. Richland, WA: ACJ & Associates.
50. Maclure M, Ben-Abraham R, Bryant MS, Skipper PL, Tannenbaum SR. (1989). Elevated blood levels of carcinogen in passive smokers. Am J Public Health, 79, 1381-1384.
51. Maclure M, Bryant MS, Skipper PL, Tannenbaum SR. (1990). Decline of the hemoglobin adduct of 4-aminobiphenyl during withdrawal from smoking. Cancer Res, 50, 181-184.
52. McAughey JJ, Knight DA, Black A, Dickens CJ. (1994). Environmental tobacco smoke retention in humans from measurements of exhaled smoke composition. Toxicol Ind Health, 6, 615-631.
53. Mooney LA, Santella RM, Covey L, Jeffrey AM, Bigbee W, Randall MC, Cooper TB, Ottman R, Tsai W-Y, Wazneh L, Glassman AH, Young T-L, Perera FP. (1995). Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev, 4, 627-634.
54. Morawska L, Barron W, Hitchins J. (1999). Experimental deposition of environmental tobacco smoke submicrometer particulate matter in the human respiratory tract. Am Ind Hyg Assoc J, 60, 334-339.
55. NRC. (1986). Environmental tobacco smoke-measuring exposure and assessing health effects. Washington, DC: National Research Council, National Academy Press.
56. Occupational Safety and Health Adminstration. (1992). Method 93 4-Aminobiphenyl. Sandy UT: Methods Development Team Industrial Hygiene Chemistry Division, US Occupational Safety and Health Adminstration.
57. Osterman-Golkar SL, Ehrenberg L, Segerback D, Hallstrom I. (1976). Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res, 34, 1-10.
58. Palmiotto G, Pieraccini G, Moneti G, Dolara P. (1997). Determination of the indoor air levels of suspected carcinogenic aromatic amines (draft for publication). Last accessed January 6, 2010, at http://legacy.library.ucsf. edu/tid/scx22d00/pdf?search=%222502254381%204402% 22.
59. Palmiotto G, Pieraccini G, Moneti G, Dolara P. (2001). Determination of the levels of aromatic amines in indoor and outdoor air in Italy. Chemosphere, 43, 355-361.
60. Pankow JF, Watanabe KH, Toccalino PL, Luo W, Austin DF. (2007). Calculated cancer risks for conventional and "potentially reduced exposure product" cigarettes. Cancer Epidemiol Biomarkers Prev, 16, 584-592.
61. Patrianakos C, Hoffmann D. (1979). Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol, 3, 150-154.
62. Perera FP, Santella RM, Brenner D, Poirier MC, Munshi AA, Fischman HK. (1987). DNA adducts, protein adducts, and sister chromatid exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst, 79, 449-456.
63. Pojer R, Whitfield J, Poulos V, Eckhard I, Richmond R, Hensley WJ. (1984). Carboxyhemoglobin, cotinine and thocyanate assay compared for distinguishing smokers from non-smokers. Clin Chem, 30, 1377-1380.
64. Repace JL, Jinot J, Bayard S, Emmons K, Hammond SK. (1998). Air nicotine and saliva cotinine as indicators of workplace passive smoking exposure and risk. Risk Anal, 18, 71-83.
65. Richter E, Branner B. (2002). Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J Chromatogr B, 778, 49-61.
66. Richter E, Rösler S, Scherer G, Gostomzyk JG, Grübl A, Krämer U, Behrendt H. (2001). Regional differences in hemoglobin adducts from aromatic amines in children. Intl Arch Occup Environ Health, 74, 421-428.
67. Robinson RJ, Yu CP. (2001). Deposition of cigarette smoke particles in the human respiratory tract. Aerosol Sci Technol, 34, 202-215.
68. Rodgman A, Perfetti TA. (2009). The chemical components of tobacco and tobacco smoke. Boca Raton, LA: CRC Press, Taylor & Francis Group.
69. Roethig HJ, Feng S, Liang Q, Liu J, Rees WA, Zedler BK. (2008). A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J Clin Pharm, 48, 580-591.
70. Sabbioni G. (1992). Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationship for the N-oxidation. Chem Biol Interact, 81, 91-117.
71. Sarkar M, Stabbert R, Kinser RD, Oey J, Rustemeier K, von Holt K, Schepers G, Walk RA, Roethig HJ. (2006). CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. Toxicol Appl Pharmacol, 213, 198-206.
72. Schepers G, Demetriou D. (2002). Determination of nicotine and its metabolites in urine by HPLC after DETBA derivatization. 8th Society for Research on Nicotine and Tobacco, February 20-23, 2002. Savannah, GA.
73. Scherer G, Engl J, Urban H-J, Gilch G, Janket D, Riedel K. (2007). Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol, 47, 171-183.
74. Skipper PL. (1993). The 4-Aminobiphenyl hemoglobin adduct as a biomarker of effect. In: Travis CC, ed. Use of Biomarkers in Assessing Health and Environmental Impacts of Chemical Pollutants. New York: Plenum Press.
75. Skipper PL, Tannenbaum SR. (1990). Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis, 11, 507-518.
76. Skipper PL, Tannenbaum SR, Ross RK, Yu MC. (2003). Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 503-507.
77. Stabbert R, Schepers G, Stinn W, Haussmann H-J. (2000). Hemoglobin adducts in rats chronically exposed to room-aged cigarette sidestream smoke and diesel engine exhaust (Abstract, poster). 6th International Symposium on Biological Reactive Intermediates. Paris, France.
78. Statistica. (1999). '99 Edition. Tulsa OK: Statsoft.
79. Stratton K, Shetty P, Wallace R, Bondurant S (eds.) (2001) Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington DC: Institute of Medicine, National Academies Press.
80. Strong JC, Black A, Knight DA, Dickens CJ, McAughey J. (1994). The regional lung deposition of thoron progeny attached to the particulate phase of environmental tobacco smoke. Rad Prot Dosim, 54, 47-56.
81. Tang D, Warburton D, Tannenbaum SR, Skipper PL, Santella RM, Simon-Cereijido G, Crawford FG, Frederica PP. (1999). Molecular and genetic damage from environmental tobacco smoke in young children. Cancer Epidemiol Biomarkers Prev, 8, 427-431.
82. Tannenbaum SR, Bryant MS, Skipper PL, Maclure M. (1986). Banbury Report 23: Mechanisms in Tobacco Carcinogenesis: Hemoglobin Adducts of Tobaccorelated Aromatic Amines: Application to Molecular Epidemiology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
83. Tardiff RG. (1997). Analysis of the ETS Exposure Monitoring Study: Distribution of Exposures to Selected ETS Chemicals Among Workers. Monterey, CA: Society for Risk Analysis.
84. Tricker AR. (2006). Biomarkers derived from nicotine and its metabolites: a review. Beitr Tabakforsch Int, 22, 147-175.
85. Tricker AR, Schorp MK, Urban HJ, Leyden D, Hagedorn HW, Engl J, Urban M, Riedel K, Gilch G, Janket D, Scherer G. (2009). Comparison of environmental tobacco smoke (ETS) concentrations generated by an electrically heated cigarette smoking system and a conventional cigarette. Inhal Toxicol, 21, 62-77.
86. Troester MA, Kupper LI, Rappaport SM. (2001). Comparison of non-linear and linear-models for estimating haemoglobin adduct stability. Biomarkers, 6, 251-261.
87. Ueda K, Kawachi I, Nakamura M, Nogami H, Shirokawa N, Masui S, Okayama A, Oshimi A. (2002). Cigarette nicotine yields and nicotine intake among Japanese male workers. Tob Control, 11, 55-60.
88. Urban H-J, Schorp M. (2006). Nicotine bridging: a new method to extend smoke constituents biomarker measurements from clinical studies to other mainstream smoke constituents. (Abstract, poster). Society for Risk Analysis Annual Meeting, December 4-6, 2006. Baltimore, MD.
89. US DHHS. (2006). The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: US Dept. of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
90. US EPA. (1992). Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. Washington DC: US Environmental Protection Agency Office of Research and Development Office of Health and Environmental Assessment. EPA/600/6-90/006F.
91. US EPA. (1997). Inhalation. In: US Environmental Protection Agency, ed. Exposure Factors Handbook. Washington DC: Office of Research and Development, National Center for Environmental Assessment, US EPA.
92. Van Hemelrijck MJ, Michaud DS, Connolly GN, Kabir Z. (2009). Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses. Cancer Epidemiol Biomarkers Prev, 18, 1312-1320.
93. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, Jacobs DR. (1990). Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study. Am J Public Health 80, 1053-1056.
94. Zedler BK, Kinser R, Oey J, Nelson B, Roethig H-J, Walk RA, Kuhl P, Rustermeier K, Schepers G, vol Holt K, Tricker AR. (2006). Biomarkers of exposure and potential harm in adult smokers of 3 to 7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers. Biomarkers, 11, 201-220.
95. Zwirner-Baier I, Deckart K, Jaeckh R, Neumann H-G. (2003). Biomonitoring of aromatic amines VI: determination of hemoglobin adducts after feeding aniline hydrochloride in the diet of rats for 4 weeks. Arch Toxicol, 77, 672-677.